FDA officials detail inspection expectations for combination products
BALTIMORE – US Food and Drug Administration (FDA) officials said that manufacturers who opt to follow a streamlined approach to their combination product current good manufacturing practice (CGMP) should be aware that the agency will closely scrutinize their risk management activities at the AFDO/RAPS Healthcare Products Collaborative Combination Products Summit on Wednesday.
19 Nov 2026 More drugmakers look to standalone medical devices for combo products BALTIMORE – Drugmakers that want to develop standalone medical devices to be used in combination with their drugs should evaluate the devices’ capabilities and requirements while engaging health authorities early, according to a panel of experts who spoke at the AFDO/RAPS Combination Products Summit on Tuesday. Regulatory News
comments(0)
5-min edit window · permanent after that